老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ensysce Biosciences Inc.

1.76
-0.1200-6.38%
盤後：1.790.0300+1.70%19:55 EDT
成交量：13.33萬
成交額：23.36萬
市值：289.47萬
市盈率：-0.15
高：1.82
開：1.80
低：1.71
收：1.88
資料載入中...
總覽公司新聞公告
2022/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/31

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

重要事件披露

8-K - Current report
2022/01/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/27

重要事件披露

8-K - Current report
2022/01/18

重要事件披露

8-K - Current report
2021/12/27

重要事件披露

8-K - Current report
2021/11/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/29

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/10/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/27

重要事件披露

8-K - Current report
2021/09/22

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/17

重要事件披露

8-K - Current report
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
更多